Nutritional and Metabolic Diseases

All Conditions

Symptoms and General Pathology

Rare Diseases

Malnutrition

Body Weight

Body Weight Changes

Kwashiorkor

Nutrition Disorders

Severe Acute Malnutrition

Acute Graft Versus Host Disease

artificial intelligence dietary application, iDSA, will be introduced and installed. Explanation on the function and application of iDSA will be given. Daily energy and macro-nutrients requirement target will bed set. The daily energy and macronutrients requirement target is secured by password. Subjects will record their daily dietary intake (food with cooking method and portion size) and nutrition impact symptoms via smartphone application at least 3 times a week. Subjects able to keep track their intake at home. During follow up session, subjects show the iDSA diet intake summary records to Researcher for further assessment.

CG will receive conventional dietitian care includes nutrition care process using conventional 24 hours diet recall method for dietary assessment

subjects use artificial intelligence dietary mobile application to monitor dietary intake

artificial intelligence dietary android mobile application

Chiou Yi Ho

Multi-center prospective pilot trial study

This is a clinical study to evaluate impact of dietary smartphone application on nutritional status among cancer patients. the study hypotheses there is improvement in nutritional outcome in intervention group if compare with control group. the eligible subjects will be screened according to inclusion criteria and approached individually to participate in this study. The consented subjects will be divided randomly into two groups, intervention and conventional groups. Conventional dietitian care will be given to conventional group (CG) while intervention group (IG) will received innovated dietitian care where they will be introduced with iDSA apps and installed in consented subjects' smartphone. All subjects will be reviewed again by dietitian in 1-month time to assess nutritional status (weight and energy protein intake) as well as nutrition impact symptoms.

The Impact of Artificial Intelligence Dietary Smartphone Application on Nutritional Status Among Cancer Patients

compare weight before intervention and after intervention

compare daily energy intake before intervention and after intervention

compare daily protein intake before intervention and after intervention

compare PG-SGA score (numerical data) before intervention and after intervention

compare NIS score (scale data) before intervention and after intervention. The score range from 1 to 5 where score 1 is better while score 5 is worst

National Cancer Institute, Malaysia

Universiti Putra Malaysia

Principal Investigator

Neoplasms

Digestive System Diseases

Gland and Hormone Related Diseases

Cholangiocarcinoma

Pancreatic Neoplasms

Duodenal Neoplasms

Gastroparesis

Adenocarcinoma

Carcinoma

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Gastrointestinal Neoplasms

Digestive System Neoplasms

Endocrine Gland Neoplasms

Gastrointestinal Diseases

Pancreatic Diseases

Endocrine System Diseases

Intestinal Neoplasms

Duodenal Diseases

Intestinal Diseases

Pancreatic Cancer

Bile Duct Cancer

Nasojejunal tube insertion was done intraopratively. Early enteral nutrition with standard enteral formulas administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.

Nasojejunal tube insertion was done intraopratively. Saline was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.

Nasojejunal tube insertion was done intraopratively. None was administered through the nasojejunal tube. Oral intake was encouraged as long as the patient can tolerate.

Naso-jejunal tube will be placed intraoperatively. The distal end of the feeding tube would be placed at 30 cm distal to Treitz ligament. Standard enteral diet, administered through a nasojejunal tube, is started on the 1st postoperative day and increased daily by 20-40 ml up to the estimated level.

After PD, enteral nutrition liquid regimen will be used step by step from postoperative day 1 to postoperative day 7.Patients are targeted to receive calories for 25 kcal/kg/day. Meanwhile, oral food intake was not restricted.

Early enteral nutrition

Naso-jejunal tube will be placed intraoperatively. The distal end of the feeding tube would be placed at 30 cm distal to Treitz ligament.

After PPPD,Only Normal Saline were given through nasojejunal tube. Entral nutrition was not administrated. Patients intake food orally at will.

Saline

nasojejunal tube insertion

Patients was encouraged to drink water on postoperative day 1, to eat liquid diet on postoperative day 2, to eat semi-solid on postoperative day 3, to eat solid food on postoperative day 4.

Oral intake

Yi Miao, Prof.

Junli Wu, MD,PhD

Jishu Wei, MD,PhD

Pancreaticoduodenectomy (PD) is the treatment of choice for resectable periampullary cancer. PD is still associated with a relatively a high incidence of delayed gastric emptying. And, there are no acknowledged strategies to avoid DGE. Several feeding strategies have been investigated to cope with this problem. However, there is still no consensus concerning the best nutrition support method after pancreaticoduodenectomy. The purpose of this study is to determine the effect of nutrition support methods on DGE after pancreaticoduodenectomy: early enteral nutrition or total parenteral nutrition.

Patients undergoing pancreatoduodenectomy will be randomized to receive early enteral nutrition (EN group), or Saline administration (Saline group), or oral intake only (Natural control). The EN group will receive standard enteral diet administered through a nasojejunal tube. Enteral nutrition will be started on the 1st postoperative day and increased daily by 20-40 ml up to the estimated level. The Saline group will receive saline administered through a nasojejunal tube beginning from the 1st postoperative day. Oral intake will not be restricted in all three group.

Enteral Nutrition After Pancreaticoduodenectomy

Effect of Enteral Nutrition on Delayed Gastric Emptying After Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial

DGE represents the inability to return to a standard diet by the end of the first postoperative week and includes prolonged nasogastric intubation of the patient. Three different grades (A,B,and C) were defined based on the impact on the clinical course and on postoperative management by ISGPS.

according to classification of Dindo-Clavien

evaluation of the occurrence of pancreatic fistulas, grade B and C, in both groups of patients

evaluation of the occurrence of hemorrhagic complications, grade B and C, in both groups of patients

Fasting plasma concentration GLP-1 level was monitored

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
The Impact of Artificial Intelligence Dietary Smartphone Application on Nutritional Status Among Cancer Patients	NCT04643626	Malnutrition, C... Malnutrition; P... Weight Change, ...	artificial inte...	18 Years -	Universiti Putra Malaysia
Enteral Nutrition After Pancreaticoduodenectomy	NCT03150615	Cancer of Pancr... Cancer of Duode... Ampulla of Vate... Cholangiocarcin...	Early enteral n... Saline nasojejunal tub... Oral intake	18 Years - 80 Years	Nanjing Medical University

Spots Global Cancer Trial Database for oral intake

Every month we try and update this database with for oral intake cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for oral intake

Every month we try and update this database with for oral intake cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for oral intake cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.